CDKN2A and neoplasm: Under normal conditions, Arf is expressed at low levels, but when stress conditions occur and oncogenes are introduced into normal cells, it induces high-level transcription of Arf, leading to the activation of p53, further inhibiting tumor progression (Matheu et al., 2008).